Captrust Financial Advisors Has $443,000 Stock Holdings in Azenta, Inc. (NASDAQ:AZTA)

Captrust Financial Advisors lessened its holdings in shares of Azenta, Inc. (NASDAQ:AZTA) by 5.2% in the third quarter, according to its most recent filing with the SEC. The firm owned 9,153 shares of the company’s stock after selling 502 shares during the period. Captrust Financial Advisors’ holdings in Azenta were worth $443,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of the business. Dimensional Fund Advisors LP grew its stake in shares of Azenta by 16.5% during the second quarter. Dimensional Fund Advisors LP now owns 2,970,964 shares of the company’s stock worth $156,331,000 after purchasing an additional 421,719 shares during the period. Allspring Global Investments Holdings LLC grew its position in shares of Azenta by 16.4% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,298,856 shares of the company’s stock worth $62,917,000 after buying an additional 183,040 shares during the period. Kayne Anderson Rudnick Investment Management LLC grew its position in shares of Azenta by 1.9% during the 2nd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 5,298,040 shares of the company’s stock worth $278,783,000 after buying an additional 100,826 shares during the period. Squarepoint Ops LLC grew its position in shares of Azenta by 433.6% during the 2nd quarter. Squarepoint Ops LLC now owns 73,055 shares of the company’s stock worth $3,844,000 after buying an additional 59,364 shares during the period. Finally, Royce & Associates LP grew its holdings in Azenta by 7.8% during the third quarter. Royce & Associates LP now owns 739,977 shares of the company’s stock valued at $35,844,000 after purchasing an additional 53,584 shares during the period. Institutional investors and hedge funds own 99.08% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on AZTA shares. Evercore ISI decreased their price objective on shares of Azenta from $53.00 to $50.00 and set an “in-line” rating for the company in a report on Tuesday, October 1st. Needham & Company LLC decreased their price target on shares of Azenta from $69.00 to $55.00 and set a “buy” rating for the company in a report on Wednesday, November 13th. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $63.60.

Azenta Stock Up 0.1 %

Azenta stock opened at $45.94 on Friday. The stock has a market capitalization of $2.09 billion, a PE ratio of -15.47 and a beta of 1.49. Azenta, Inc. has a twelve month low of $38.82 and a twelve month high of $69.16. The company has a 50 day moving average of $44.60 and a 200-day moving average of $49.58.

Azenta (NASDAQ:AZTA) last posted its quarterly earnings data on Tuesday, November 12th. The company reported $0.18 earnings per share for the quarter, topping the consensus estimate of $0.10 by $0.08. The company had revenue of $170.00 million during the quarter, compared to analysts’ expectations of $169.66 million. Azenta had a positive return on equity of 1.03% and a negative net margin of 25.01%. Azenta’s revenue for the quarter was down 1.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.13 earnings per share. Equities analysts anticipate that Azenta, Inc. will post 0.41 EPS for the current fiscal year.

Insider Buying and Selling

In related news, CEO John Marotta purchased 12,717 shares of Azenta stock in a transaction that occurred on Monday, November 18th. The stock was purchased at an average cost of $39.48 per share, with a total value of $502,067.16. Following the completion of the transaction, the chief executive officer now owns 99,612 shares of the company’s stock, valued at approximately $3,932,681.76. This trade represents a 14.63 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director William L. Cornog purchased 12,500 shares of Azenta stock in a transaction that occurred on Monday, November 18th. The shares were bought at an average cost of $39.60 per share, with a total value of $495,000.00. Following the completion of the transaction, the director now directly owns 14,755 shares of the company’s stock, valued at approximately $584,298. The trade was a 554.32 % increase in their position. The disclosure for this purchase can be found here. Over the last 90 days, insiders sold 3,018 shares of company stock worth $126,689. 1.77% of the stock is owned by insiders.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.